pentadecapeptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-09-15 and is reviewed periodically as new material appears.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Assessed by visual inspection under ordinary laboratory lighting |
| Molecular mass | Approximately 1419 Da | Monoisotopic mass for the fifteen-residue sequence |
| Solubility class | Freely soluble in water | Stock solutions commonly prepared in water or aqueous buffer |
| Typical storage temperature | -20 °C or below, desiccated | Lyophilized powder; repeated freeze-thaw cycles are usually avoided |
| Common analytical method | Reversed-phase HPLC with UV detection | Frequently paired with mass spectrometry to confirm identity |
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
== Mathematical analysis of the FcRn mechanism == Antibody binding, salvage and recycling by FcRn is an important part of modelling antibody pharmacokinetics. In fact, besides target-mediated drug dispostiion (TMDD), it is one of the most important factors mediating (non-specific) antibody elimination. Such a mechanism lies at the core of most physiology-based pharmacokinetic (PBPK) models of antibodies, see e.g. Garg and Balthasar, 2007; Shah and Betts, 2012; Niederal et al., 2018; Glassman and Balthasar, 2019; de Witte et al., 2023; De Sutter et al. (2024). Some of first steps towards understanding and gaining mathematical insight into the FcRn mechanism was taken by Patsatzis et al. (2022), using the computational singular perturbation (CSP) approach to analyse a minimal FcRn model. This preliminary work was extended and deepend by Katai et al. (2024) using the method of matched asymptotic expansions. This latter work constituted an asymptotic analysis of the mechanism in the high binding affinity limit, i.e. where binding was assumed to be an order of magnitude faster than all other processes. This resulted in a three-tiered scaling framework for non-saturating doses, with binding on the fastest time scale (typically over seconds or minutes), all other cellular process on an intermediate time scale (hours) and a long 'effective' elimination time scale (days, weeks).
Artificial intelligence provides a number of tools that are useful to bad actors, such as authoritarian governments, terrorists, criminals or rogue states. There are many ways in which AI is expected to help bad actors, some of which cannot be foreseen. For example, machine-learning AI is able to design tens of thousands of toxic molecules in a matter of hours.
(2026) determine the age of the carbon black-based figures in the rock art from the Font-de-Gaume cave (France) on the basis of chemical imaging and radiocarbon dating. Parfitt et al. (2026) identify an Upper Paleolithic pendant made out of a polished seal tooth from the Kents Cavern (United Kingdom), which was an inland site during the Magdalenian occupation. Allaby et al. (2026) reconstruct the environment of the Southern River system in southern Doggerland on the basis of sedimentological and sedimentary ancient DNA, and report evidence indicating that early colonization of Doggerland was facilitated by presence of northern refugia during the early Mesolithic. Evidence indicating that early Paleo-Indians from eastern Beringia, North American Clovis complex and South American Fishtail Projectile Point complex were dietary specialists feeding on Pleistocene megafauna is presented by Potter et al. (2026). Eren et al. (2026) argue that Pleistocene sites in North America with proboscidean remains associated with Clovis points representing hunting and scavenging events cannot be reliably distinguished on the basis of available evidence, and argue that Clovis foragers likely practiced both hunting and scavenging of large Pleistocene mammals. Evidence from the study of assemblages of Pleistocene perishable objects from the Cougar Mountain Cave and Paisley Caves (Oregon, United States), indicative of complexity and sophistication of perishable technologies in the North American Great Basin during the Late Pleistocene, is presented by Rosencrance et al. (2026).
== Treatments == Cellulite can be resistant to a variety of treatments. Aside from "topical" products (creams, ointments) and injectables (collagenase), treatments for cellulite include non-invasive therapy such as mechanical suction or mechanical massage. Energy-based devices include radio frequency with deep penetration of the skin, ultrasound, cryotherapy chambers, laser and pulsed-light devices. Combinations of mechanical treatments and energy-based procedures are widely used. Ionithermie, a form of electrotherapy using electrical muscle stimulation, has been described as ineffective. More invasive 'subcision' techniques utilize a needle-sized microscalpel to cut through the causative fibrous bands of connective tissue. Subcision procedures (manual, vacuum-assisted, or laser-assisted) are performed in specialist clinics with patients given local anaesthetic.
=== Eddy viscosity === In the study of turbulence in fluids, a common practical strategy is to ignore the small-scale vortices (or eddies) in the motion and to calculate a large-scale motion with an effective viscosity, called the "eddy viscosity", which characterizes the transport and dissipation of energy in the smaller-scale flow (see large eddy simulation). In contrast to the viscosity of the fluid itself, which must be positive by the second law of thermodynamics, the eddy viscosity can be negative.
Sources: en.wikipedia.org
Finnegan (1928), director of the Federal Mediation and Conciliation Service 1955–1961 Wolf Ladejinsky (1928), agricultural economist and researcher and key adviser on land reform in Asian countries James T. O'Connell (1928), U.S. deputy secretary of labor 1957–1961 James J. Reynolds (1928), U.S. deputy secretary of labor 1967–1969 William H. Shaw (1930), assistant secretary of commerce for Economic Affairs 1966–1968 Boris Shishkin (1930), member of the President's Committee on Civil Rights and head of the AFL–CIO Department of Civil Rights Arthur E. Goldschmidt (1932), United States ambassador to the United Nations Economic and Social Council 1967–1969 Reed Harris (1932), former deputy director of the United States Information Agency and victim of McCarthyism James Hagerty (1934), White House press secretary 1953–1961 Hickman Price (1934), assistant secretary in the United States Department of Commerce 1961–1963; Kaiser-Frazer and Willys executive Faubion Bowers* (1935), General Douglas MacArthur's interpreter and aide-de-camp during the Allied Occupation of Japan Hunter Meighan (1935), member of the New York State Assembly and the New York State Senate Thomas Karamessines (1938), deputy director of CIA for operations 1967–1973 A. Gerdes Kuhbach (1938), executive director of the Port Authority of New York and New Jersey 1973–1977 Thibaut de Saint Phalle (1939), director of the Export–Import Bank of the United States 1977–1981 Arthur R. Albohn (1942), member of the New Jersey General Assembly Richard T. Davies (1942), former U.S. ambassador to Poland David E.
Surrounding skin: Appearance of the surrounding skin can provide clues to underlying disease processes, such as redness/erythema due to cellulitis, maceration due to uncontrolled wound exudate, or eczematous changes due to a chronic irritation (e.g. allergic reaction to wound dressing). Infection: Classic signs of infection are redness, warmth, swelling, odor, and pain out of proportion to wound appearance. Pain: Pain can be nociceptive, neuropathic, or inflammatory, each of which can provide clues to the cause of a wound. Proper pain control is an important consideration in wound management, particularly in burn care where analgesia is often necessary prior to dressing changes. A thorough wound evaluation, particularly evaluation of wound depth and removal of necrotic tissue, should be performed only by a licensed healthcare professional in order to avoid damage to nearby structures, infection, or worsening pain.
=== Use and abuse === Flupentixol/melitracen is the single most popular antidepressant in China, according to 2013–2018 prescription data. It is generally not prescribed by psychiatrists, but by clinicians working in other areas, mainly gastroenterologists, cardiologists, endocrinologists, neurologists, even general physicians and surgeons. Only when a patient encounters a side effect on this drug are they referred to a psychiatrist. DXY.cn notes a significant lack of evidence-based guidance on using and discontinuing this medication despite its widespread use in China. Adverse effects from longer-term use and withdrawal symptoms have been reported. Self-medication with this drug used to be common in India; it still is in China, where pharmacies exercise little care to ensure the existence of a prescription. It is also easily obtained in Lebanon without a prescription. In a study of Lebanese emergency department patients who take flupentixol/melitracen, 36% (45 out of 125) were diagnosed as having a substance use disorder for this medication under the DSM-V criteria. Among Jordanian pharmacists, 70.6% were willing to dispense the medication in situations including malpractice.
== Death == Sun likely spent the last few years of his life as a monk, before working as a caretaker of the Guanghua temple in Beijing. He lived there until his death on 17 December 1996 at the age of 93.
Sources: en.wikipedia.org
It is a synthetic peptide built from fifteen amino acids, with a mass of roughly 1419 daltons. The sequence is reported to match a fragment of a protein present in human gastric juice. It is not a naturally circulating hormone.
It is normally supplied as a lyophilized powder in a sealed vial. The powder dissolves readily in water, and stock solutions are typically prepared shortly before use. Cold storage is standard laboratory practice.
The letters are generally read as shorthand for body protection compound. That label comes from the original research context rather than from formal nomenclature. No standardized nonproprietary name exists for the peptide.
It is a synthetic peptide of fifteen amino acids whose sequence matches a fragment of a protein found in human gastric juice. It is studied mainly in laboratory and animal research rather than as an approved medicine.